Instead, ERK5-mediated signalling appears to critically regulate cellular motility and invasion in PCa, which is in keeping with our observed association between aberrant ERK5 expression in the primary prostate tumours and a less favourable survival outcome (McCracken et al, 2008). The gene discussed is MAPK7; the disease is posterior cortical atrophy.